ANAVEX LIFE SCIENCES CORP. 10-Q

ITEM 5. OTHER INFORMATION None 40 ITEM 6. EXHIBITS Exhibit Number Description (3) Articles of Incorporation and Bylaws 3.1 Articles of Incorporation (incorporated by reference to Exhibit 3.1 to our Annual Report on Form 10-K for the year ended September 30, 2021 filed on November 24, 2021) 3.2 Bylaws (incorporated by reference to our Current Report on Form 8-K filed on April 14, 2023) (31) Rule 13a-14(a)/15(d)-14(a)Certifications 31.1* Certification of Christopher Missling, PhD. 31.2* Certification of Sandra Boenisch (32) Section 1350 Certifications 32.1** Certification of Christopher Missling, PhD and Sandra Boenisch. (101) XBRL 101.INS* XBRL INSTANCE DOCUMENT 101.SCH* XBRL TAXONOMY EXTENSION SCHEMA 101.CAL* XBRL TAXONOMY EXTENSION CALCULATION LINKBASE 101.DEF* XBRL TAXONOMY EXTENSION DEFINITION LINKBASE 101.LAB* XBRL TAXONOMY EXTENSION LABEL LINKBASE 101.PRE* XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE * Filed herewith. ** Furnished herewith. 41 SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. ANAVEX LIFE SCIENCES CORP. /s/Christopher Missling, PhD Christopher Missling, PhD Chief Executive Officer (Principal Executive Officer) Date: February 7, 2024 /s/Sandra Boenisch Sandra Boenisch, CPA, CGA Principal Financial Officer (Principal Financial and Accounting Officer) Date: February 7, 2024 42